SHORT COURSE DURATION SOFOSBUVIR/VELPATASVIR IS INFERIOR TO STANDARD DURATION THERAPY IN THE TREATMENT OF RECENTLY ACQUIRED HCV INFECTION: RESULTS FROM REACT STUDY

导出原文传递

翻译打印收藏纠错

作者： Matthews, Gail ^[1] ; Bhagani, Sanjay ^[2] ; Van der Valk, Marc ^[3] ; Rockstroh, Juergen K. ^[4] ; Kim, Arthur Y. ^[5] ; Thurnheer, Christine ^[6] ; Feld, Jordan J. ^[7] ; Bruneau, Julie ^[8] ; Gane, Edward J. ^[9] ; Hellard, Margaret ^[10] ; Grebely, Jason ; Applegate, Tanya ; Marks, Pip ; Martinello, Marianne ; Petoumenos, Kathy ; Dore, Gregory

作者单位： Bern Univ Hosp, Bern, Switzerland ^[1] Auckland City Hosp, Auckland, New Zealand ^[2] Univ Hosp Bonn, Dept Internal Med 1, Bonn, Germany ^[3] Unsw Sydney, Kirby Inst, Sydney, NSW, Australia ^[4] Acad Med Ctr, Amsterdam, Netherlands ^[5] Royal Free NHS Fdn Trust, Infect Dis, London, England ^[6] MGH, Infect Dis Unit, Boston, MA USA ^[7] Univ Toronto, Univ Hlth Network, Toronto Ctr Liver Dis, Toronto, ON, Canada ^[8] CRCHUM, Montreal, PQ, Canada ^[9] Alfred Hosp, Melbourne, Vic, Australia ^[10]

发布时间 2021-01-31

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Hepatology

2019年70卷6期

1487A-1488A页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

SHORT COURSE DURATION SOFOSBUVIR/VELPATASVIR IS INFERIOR TO STANDARD DURATION THERAPY IN THE TREATMENT OF RECENTLY ACQUIRED HCV INFECTION: RESULTS FROM REACT STUDY

Hepatology

相似文献

Hepatology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

SHORT COURSE DURATION SOFOSBUVIR/VELPATASVIR IS INFERIOR TO STANDARD DURATION THERAPY IN THE TREATMENT OF RECENTLY ACQUIRED HCV INFECTION: RESULTS FROM REACT STUDY

Hepatology

相似文献

Hepatology

相关期刊

检索历史清除